A lot-specific Certificate of Analysis (COA) serves as the definitive analytical proof of a peptide's identity, purity, and safety profile in laboratory settings. For researchers evaluating the synthetic melanocortin analog Melanotan II, comprehensive analytical documentation ensures reproducible experimental results across in vitro assays and preclinical models.
A lot-specific Certificate of Analysis (COA) serves as the definitive analytical proof of a peptide's identity, purity, and safety profile in laboratory settings. For researchers evaluating the synthetic melanocortin analog Melanotan II, comprehensive analytical documentation ensures reproducible experimental results across in vitro assays and preclinical models.
In modern biochemical research, the integrity of experimental data relies entirely on the consistency and purity of target reagent compounds. A Certificate of Analysis (COA) is an official analytical document provided by an independent or certified testing laboratory that details the exact chemical characterization of a specific manufacturing lot. When procuring compounds such as Melanotan II, investigators must evaluate the lot-specific COA to ensure that sample matrix artifacts, sequence truncations, or synthesis impurities do not confound research outcomes.
Without rigorous analytical documentation, variation in peptide content, counter-ion balance, residual organic solvents, or bacterial endotoxins can invalidate cell culture assays and animal studies. Authentic research facilities mandate that every batch undergo independent verification via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) prior to experimental deployment. PX1 Research adheres strictly to these standards, making lot-specific analytical reports accessible across our entire catalog of research peptides.
Melanotan II is a synthetic, cyclic heptapeptide analog of the naturally occurring endogenous signaling peptide alpha-melanocyte-stimulating hormone (α-MSH). Chemically designated as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, the compound possesses a lactam bridge formed between the side chains of the aspartic acid and lysine residues. This cyclic structure confers enhanced conformational stability and metabolic resistance compared to linear endogenous peptide sequences.
The molecular formula of Melanotan II is C50H69N15O9, with a theoretical monoisotopic molecular weight of 1023.54 Da and an average molecular weight of approximately 1024.2 g/mol. Preclinical studies indicate that this cyclic design enables high-affinity binding across multiple melanocortin receptor subtypes (MC1R, MC3R, MC4R, and MC5R). When interpreting a melanotan ii coa, researchers must confirm that the observed mass matches these theoretical values down to the decimal fragment to rule out structural isomers or incomplete side-chain deprotection during solid-phase peptide synthesis (SPPS).
High-Performance Liquid Chromatography (HPLC) is the gold-standard analytical method used to measure chemical purity and identify trace organic impurities in synthetic peptides. Reversed-Phase HPLC (RP-HPLC) utilizes a hydrophobic stationary phase (typically a C18 silica column) and a polar mobile phase gradient (water and acetonitrile containing trifluoroacetic acid as an ion-pairing agent) to separate the target peptide from synthesis side products.
A valid COA displays a clear HPLC chromatogram with a singular, sharp absorption peak corresponding to the target analyte. Peptide purity is calculated using the relative peak area method (Area Under the Curve or AUC percentage). For high-precision laboratory investigations, researchers should demand a minimum HPLC purity threshold of 98.0%. Minor peaks surrounding the main analyte peak represent deletion sequences, diastereomers, or oxidation products generated during SPPS. PX1 Research subjects all peptide batches to standardized peptide purity testing in ISO 17025 accredited laboratory environments to verify that impurity profiles remain within strict allowable thresholds.
While HPLC determines the chemical purity percentage of a sample, it cannot definitively confirm the molecular identity of the primary chromatographic peak. Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) is required to determine the exact mass-to-charge ratio (m/z) of the synthesized peptide.
In an analytical report, the MS spectrum displays the dominant ionization state peaks—frequently the protonated species [M+H]+, [M+2H]2+, or [M+3H]3+. For Melanotan II, ESI-MS typically displays a strong singly charged peak around m/z 1024.5 or a doubly charged species [M+2H]2+ around m/z 512.8. Matching these empirical mass values against calculated target masses provides unambiguous confirmation that the correct peptide sequence was synthesized without amino acid deletions, unexpected salt adducts, or incorrect protecting group removal.
Endotoxins are lipopolysaccharide (LPS) complexes derived from the outer cell membrane of Gram-negative bacteria. During solid-phase peptide synthesis and downstream handling, environmental bacteria can introduce endotoxins into the reagent matrix. In biological assays, excessive endotoxin concentrations trigger unintended inflammatory signaling pathways via Toll-like Receptor 4 (TLR4), confounding research results in cell cultures and animal models.
Endotoxin testing is conducted using the Limulus Amebocyte Lysate (LAL) assay or recombinant Factor C (rFC) fluorescence assay. Quantitative endotoxin results on a COA are expressed in Endotoxin Units per milligram (EU/mg). For sensitive cell culture and in vivo research applications, endotoxin levels should routinely test below 0.1 EU/mg, and ideally below 0.01 EU/mg. PX1 Research enforces strict bioburden controls across all synthesis pathways, verifying low-endotoxin compliance through independent lot testing.
A comprehensive Certificate of Analysis provides physical and chemical parameter checks beyond chromatographic purity and mass validation. These secondary metrics ensure stability, solubility, and correct formulation upon reconstitution:
- **Visual Appearance:** Lyophilized Melanotan II should present as a uniform, white to off-white cake or lyophilized powder. Clumping, discoloration, or liquid remnants indicate incomplete freeze-drying or moisture exposure during packaging.
- **Moisture Content (Karl Fischer Titration):** Residual water accelerates peptide hydrolytic degradation over time. High-quality lyophilized peptides maintain moisture content below 5.0% by weight.
- **Solubility & Solution Clarity:** Reconstitution in sterile bacteriostatic water or standard phosphate-buffered saline (PBS) should yield a completely clear, colorless solution devoid of visible particulates or insoluble aggregation.
- **Residual Solvents (GC-MS):** Solid-phase synthesis relies on organic solvents like dimethylformamide (DMF), dichloromethane (DCM), and trifluoroacetic acid (TFA). A thorough COA confirms that residual organic solvents reside within safe USP <467> limits.
Melanotan II serves as a vital tool compound for investigating central and peripheral melanocortin signaling pathways. Preclinical studies suggest that Melanotan II operates as a non-selective melanocortin receptor agonist with demonstrated activity at MC1R, MC3R, MC4R, and MC5R:
- **MC1R Interaction:** Primary research explores MC1R activation in cutaneous melanocytes, evaluating melanogenesis pathways, baseline eumelanin synthesis, and skin pigmentation responses in animal models.
- **MC3R / MC4R Interaction:** Central melanocortin receptor activity is studied in relation to energy homeostasis, substrate utilization, and central nervous system signaling pathways.
- **MC5R Interaction:** Exocrine gland secretion and peripheral metabolic research frequently monitor MC5R activity following exposure to cyclic melanocortin analogs.
Because these receptor interactions depend on precise ligand-binding dynamics, variable purity or incorrect peptide folding can severely skew experimental binding affinity assays (Ki/Kd values). Researchers rely on high-purity, validated compounds to ensure consistent receptor activity across experimental cohorts.
When designing melanocortin receptor experiments, researchers frequently compare Melanotan II against structurally or functionally related peptides within the melanocortin class. Understanding the analytical and functional differences across these compounds is essential for proper experimental setup.
For instance, Melanotan I (Afamelanotide) is a linear tridecapeptide analog ([Nle4, D-Phe7]-α-MSH) that demonstrates selective binding affinity toward MC1R, whereas Melanotan II features a condensed cyclic structure that displays higher potency and broader affinity across MC3R and MC4R. Another related compound, Bremelanotide PT-141, is a metabolite-derived cyclic analog of Melanotan II that retains a hydroxylated C-terminus, making it a key focus in central melanocortin receptor research. Additionally, anti-inflammatory melanocortin research often utilizes small fragments such as the tripeptide KPV peptide, which targets distinct downstream signaling mechanisms independent of classical pigmentary pathways. Each compound requires distinct HPLC mobile-phase gradients and reference mass standards on its respective COA.
PX1 Research is committed to setting the industry baseline for reagent transparency and quality assurance. Every batch of Melanotan II offered for laboratory research undergoes synthesis in domestic, GMP-compliant facilities within the United States. Following synthesis, representative samples are transferred to independent ISO 17025 accredited testing laboratories for full analytical characterization.
Our analytical validation protocol requires:
1. **Full-Spectrum RP-HPLC:** Confirming sample purity >98.0% with complete baseline separation.
2. **ESI-MS Analysis:** Verifying exact molecular weight and structural identity.
3. **LAL Endotoxin Assay:** Ensuring endotoxin limits fall well within strict research safety guidelines.
4. **Batch Consistency Verification:** Cross-referencing lot numbers to guarantee zero inter-batch variability.
All analytical COAs are published directly for research review. Orders placed through PX1 Research ship same-day (Monday through Friday) from our CA and AZ distribution centers, ensuring rapid delivery of high-purity reagents to academic, private, and institutional laboratories. Institutional buyers and lab directors seeking high-volume procurement can access dedicated supply chains through our wholesale research accounts.
What essential metrics should a valid Melanotan II COA include?
A legitimate Melanotan II COA must include lot-specific RP-HPLC purity percentage (minimum 98%), ESI-MS or MALDI-TOF mass confirmation matching the calculated molecular weight (~1024.2 g/mol), LAL endotoxin quantification, moisture content (Karl Fischer), and visual appearance verification.
How does HPLC determine the purity of Melanotan II?
Reversed-Phase HPLC separates Melanotan II from synthesis impurities using a C18 column and acetonitrile gradient. The UV absorption spectrum measures the relative Area Under the Curve (AUC) of the target peptide peak compared to all detected impurity peaks, yielding an exact purity percentage.
Why is mass spectrometry necessary if HPLC purity is high?
HPLC measures chemical separation and relative purity, but it cannot verify the exact sequence identity of the molecule. Mass spectrometry (MS) measures the mass-to-charge ratio (m/z) to prove that the peak observed in HPLC is definitively Melanotan II rather than a synthetic isomer or incorrect sequence.
What is the acceptable endotoxin threshold for research-grade peptides?
For sensitive in vitro cellular models and preclinical research, endotoxin levels should ideally be below 0.1 EU/mg, with premium research lots testing below 0.01 EU/mg to prevent non-specific immune pathway activation via TLR4.
How should Melanotan II be stored upon receipt in the laboratory?
Lyophilized Melanotan II powder should be stored at -20°C or -80°C in a desiccated environment protected from light. Once reconstituted with sterile reconstituted solvent, liquid aliquots should be kept refrigerated at 2–8°C for short-term use or frozen at -20°C to avoid repeated freeze-thaw cycles.
What is the difference between Melanotan I and Melanotan II on a COA?
Melanotan I (Afamelanotide) is a linear tridecapeptide with a molecular weight of ~1646.85 Da, whereas Melanotan II is a cyclic heptapeptide with a molecular weight of ~1024.2 Da. Their COAs reflect completely distinct mass spectrometry spectra, retention times, and theoretical masses.
Are PX1 Research compounds synthesized in the USA?
Yes. All PX1 Research compounds are USA-synthesized in GMP-compliant facilities and undergo independent analytical testing in ISO 17025 accredited laboratories prior to batch release.
Can Melanotan II be ordered for human clinical use or personal administration?
No. Melanotan II supplied by PX1 Research is strictly a research compound intended solely for laboratory research use, in vitro assays, and preclinical research applications. It is not for human, clinical, or therapeutic use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.